GJA1

gap junction protein alpha 1, the group of Gap junction proteins

Basic information

Region (hg38): 6:121435595-121449727

Previous symbols: [ "ODDD", "GJAL" ]

Links

ENSG00000152661NCBI:2697OMIM:121014HGNC:4274Uniprot:P17302AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • Hallermann-Streiff syndrome (Limited), mode of inheritance: AR
  • hypoplastic left heart syndrome 1 (Definitive), mode of inheritance: AD
  • syndactyly type 3 (Limited), mode of inheritance: AD
  • oculodentodigital dysplasia, autosomal recessive (Definitive), mode of inheritance: AR
  • oculodentodigital dysplasia (Definitive), mode of inheritance: AD
  • autosomal dominant palmoplantar keratoderma and congenital alopecia (Strong), mode of inheritance: AD
  • erythrokeratodermia variabilis et progressiva 3 (Strong), mode of inheritance: AD
  • oculodentodigital dysplasia (Definitive), mode of inheritance: Semidominant
  • syndactyly type 3 (Limited), mode of inheritance: AD
  • autosomal dominant palmoplantar keratoderma and congenital alopecia (Limited), mode of inheritance: AD
  • craniometaphyseal dysplasia, autosomal recessive (Limited), mode of inheritance: AR
  • erythrokeratodermia variabilis et progressiva 3 (Limited), mode of inheritance: AD
  • autosomal dominant palmoplantar keratoderma and congenital alopecia (Supportive), mode of inheritance: AD
  • craniometaphyseal dysplasia (Supportive), mode of inheritance: AD
  • oculodentodigital dysplasia (Supportive), mode of inheritance: AD
  • erythrokeratodermia variabilis (Supportive), mode of inheritance: AD
  • syndactyly type 3 (Supportive), mode of inheritance: AD
  • craniometaphyseal dysplasia, autosomal recessive (Limited), mode of inheritance: Unknown
  • erythrokeratodermia variabilis et progressiva 3 (Strong), mode of inheritance: AD
  • oculodentodigital dysplasia, autosomal recessive (Strong), mode of inheritance: AR
  • oculodentodigital dysplasia (Strong), mode of inheritance: AD
  • syndactyly type 3 (Limited), mode of inheritance: Unknown
  • nonsyndromic genetic hearing loss (Disputed Evidence), mode of inheritance: AD

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Oculodentodigital dysplasia; Hypoplastic left heart syndrome 1; Atrioventricular septal defect 3AD/ARCardiovascularIndividuals with congenital heart anomalies may benefit from early diagnosis and intervention; Individuals with cardiac arrhythmias have been reported, and surveillance (eg, with EKG) may allow early detection and treatmentCardiovascular; Craniofacial; Dental; Dermatologic; Endocrine; Musculoskeletal; Neurologic; Ophthalmologic2157843; 7815444; 11470490; 12457340; 15108203; 14974090; 14729836; 14981729; 15551259; 15637728; 16709485; 16816024; 17256797; 18412120; 19338053; 21670345; 22179534; 22214631; 23951358; 25168385; 25398053

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the GJA1 gene.

  • Oculodentodigital dysplasia, autosomal recessive (9 variants)
  • Oculodentodigital dysplasia (6 variants)
  • not provided (2 variants)
  • 8 conditions (1 variants)
  • Cutaneous finger syndactyly;Intellectual disability;Anteverted nares;Bilateral microphthalmos (1 variants)
  • GJA1-related disorder (1 variants)
  • Inborn genetic diseases (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the GJA1 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
5
clinvar
55
clinvar
60
missense
14
clinvar
15
clinvar
105
clinvar
1
clinvar
135
nonsense
1
clinvar
1
clinvar
3
clinvar
5
start loss
0
frameshift
1
clinvar
1
clinvar
3
clinvar
5
inframe indel
2
clinvar
5
clinvar
7
splice donor/acceptor (+/-2bp)
0
splice region
0
non coding
32
clinvar
3
clinvar
7
clinvar
42
Total 16 19 153 59 7

Variants in GJA1

This is a list of pathogenic ClinVar variants found in the GJA1 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
6-121435652-T-G Hypoplastic left heart syndrome 1 • Oculodentodigital dysplasia • Syndactyly type 3 Uncertain significance (Jan 13, 2018)904853
6-121435661-G-T Hypoplastic left heart syndrome 1 • Syndactyly type 3 • Oculodentodigital dysplasia Uncertain significance (Jan 12, 2018)355154
6-121435688-G-T Syndactyly type 3 • Oculodentodigital dysplasia • Hypoplastic left heart syndrome 1 Uncertain significance (Jan 13, 2018)355155
6-121435714-C-T Hypoplastic left heart syndrome 1 • Syndactyly type 3 • Oculodentodigital dysplasia Conflicting classifications of pathogenicity (Jan 13, 2018)355156
6-121435762-C-T Hypoplastic left heart syndrome 1 • Oculodentodigital dysplasia • Syndactyly type 3 Uncertain significance (Jan 12, 2018)906469
6-121435782-C-G Syndactyly type 3 • Oculodentodigital dysplasia • Hypoplastic left heart syndrome 1 Conflicting classifications of pathogenicity (Feb 05, 2022)355157
6-121435882-C-T Benign (May 18, 2021)1232249
6-121435925-T-G Benign (May 17, 2021)1288826
6-121446820-T-A Hypoplastic left heart syndrome 1 • Oculodentodigital dysplasia • Syndactyly type 3 Conflicting classifications of pathogenicity (Oct 28, 2019)355158
6-121446820-T-C Likely benign (May 19, 2020)1200337
6-121446862-C-T Oculodentodigital dysplasia, autosomal recessive • not specified Likely benign (Aug 21, 2023)1628704
6-121446865-C-T Oculodentodigital dysplasia, autosomal recessive Likely benign (Mar 20, 2023)1658324
6-121446870-G-T Autosomal dominant palmoplantar keratoderma and congenital alopecia Pathogenic (Jan 01, 2015)203467
6-121446878-C-T Oculodentodigital dysplasia Pathogenic (Jun 01, 2011)29668
6-121446879-T-A Oculodentodigital dysplasia, autosomal recessive Pathogenic (Jan 25, 2024)2705428
6-121446879-T-C Oculodentodigital dysplasia Pathogenic (May 01, 2006)16993
6-121446884-A-G Uncertain significance (Aug 02, 2022)2428806
6-121446897-A-C Oculodentodigital dysplasia Pathogenic (Feb 01, 2003)16982
6-121446899-T-C Oculodentodigital dysplasia Pathogenic (Feb 01, 2003)16983
6-121446900-C-A Oculodentodigital dysplasia, autosomal recessive Pathogenic (Mar 20, 2022)941060
6-121446908-G-A Oculodentodigital dysplasia Pathogenic (Feb 01, 2003)16984
6-121446911-G-A Oculodentodigital dysplasia, autosomal recessive Pathogenic (Apr 26, 2019)844190
6-121446912-G-A Oculodentodigital dysplasia • Oculodentodigital dysplasia, autosomal recessive Pathogenic (May 06, 2022)16985
6-121446913-G-A Oculodentodigital dysplasia, autosomal recessive Likely benign (Oct 04, 2022)1654046
6-121446922-G-C Inborn genetic diseases Pathogenic/Likely pathogenic (Jun 11, 2021)986183

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
GJA1protein_codingprotein_codingENST00000282561 114036
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.1550.8421257350131257480.0000517
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense1.281502010.7460.00001182506
Missense in Polyphen1762.9190.27019862
Synonymous-2.6511180.71.380.00000486760
Loss of Function2.58414.70.2730.00000117151

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0001730.000173
Ashkenazi Jewish0.000.00
East Asian0.00005440.0000544
Finnish0.000.00
European (Non-Finnish)0.00004400.0000439
Middle Eastern0.00005440.0000544
South Asian0.00003270.0000327
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Gap junction protein that acts as a regulator of bladder capacity. A gap junction consists of a cluster of closely packed pairs of transmembrane channels, the connexons, through which materials of low MW diffuse from one cell to a neighboring cell. May play a critical role in the physiology of hearing by participating in the recycling of potassium to the cochlear endolymph. Negative regulator of bladder functional capacity: acts by enhancing intercellular electrical and chemical transmission, thus sensitizing bladder muscles to cholinergic neural stimuli and causing them to contract (By similarity). May play a role in cell growth inhibition through the regulation of NOV expression and localization. Plays an essential role in gap junction communication in the ventricles (By similarity). {ECO:0000250|UniProtKB:P08050, ECO:0000250|UniProtKB:P23242}.;
Disease
DISEASE: Oculodentodigital dysplasia (ODDD) [MIM:164200]: A disease characterized by a typical facial appearance and variable involvement of the eyes, dentition, and fingers. Characteristic facial features include a narrow, pinched nose with hypoplastic alae nasi, prominent columella and thin anteverted nares together with a narrow nasal bridge, and prominent epicanthic folds giving the impression of hypertelorism. The teeth are usually small and carious. Typical eye findings include microphthalmia and microcornea. The characteristic digital malformation is complete syndactyly of the fourth and fifth fingers (syndactyly type III) but the third finger may be involved and associated camptodactyly is a common finding. Cardiac abnormalities are observed in rare instances. {ECO:0000269|PubMed:12457340, ECO:0000269|PubMed:14729836, ECO:0000269|PubMed:15108203, ECO:0000269|PubMed:15637728, ECO:0000269|PubMed:16219735, ECO:0000269|PubMed:16222672, ECO:0000269|PubMed:16378922, ECO:0000269|PubMed:16709485, ECO:0000269|PubMed:16813608, ECO:0000269|PubMed:16816024, ECO:0000269|PubMed:17509830, ECO:0000269|PubMed:18161618, ECO:0000269|PubMed:19338053, ECO:0000269|PubMed:21670345, ECO:0000269|PubMed:23550541, ECO:0000269|PubMed:24508941, ECO:0000269|PubMed:28258662}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Oculodentodigital dysplasia, autosomal recessive (ODDD- AR) [MIM:257850]: A disease characterized by a typical facial appearance and variable involvement of the eyes, dentition, and fingers. Characteristic facial features include a narrow, pinched nose with hypoplastic alae nasi, prominent columella and thin anteverted nares together with a narrow nasal bridge, and prominent epicanthic folds giving the impression of hypertelorism. The teeth are usually small and carious. Typical eye findings include microphthalmia and microcornea. The characteristic digital malformation is complete syndactyly of the fourth and fifth fingers (syndactyly type III) but the third finger may be involved and associated camptodactyly is a common finding. Cardiac abnormalities are observed in rare instances. {ECO:0000269|PubMed:16816024}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Syndactyly 3 (SDTY3) [MIM:186100]: A form of syndactyly, a congenital anomaly of the hand or foot marked by persistence of the webbing between adjacent digits that are more or less completely attached. In SDTY3, there is usually complete and bilateral syndactyly between the fourth and fifth fingers. Usually it is soft tissue syndactyly but occasionally the distal phalanges are fused. The fifth finger is short with absent or rudimentary middle phalanx. The feet are not affected. {ECO:0000269|PubMed:14729836}. Note=The disease may be caused by mutations affecting the gene represented in this entry.; DISEASE: Hypoplastic left heart syndrome 1 (HLHS1) [MIM:241550]: A syndrome due to defective development of the aorta proximal to the entrance of the ductus arteriosus, and hypoplasia of the left ventricle and mitral valve. As a result of the abnormal circulation, the ductus arteriosus and foramen ovale are patent and the right atrium, right ventricle, and pulmonary artery are enlarged. {ECO:0000269|PubMed:11470490}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Hallermann-Streiff syndrome (HSS) [MIM:234100]: A disorder characterized by a typical skull shape (brachycephaly with frontal bossing), hypotrichosis, microphthalmia, cataracts, beaked nose, micrognathia, skin atrophy, dental anomalies and proportionate short stature. Mental retardation is present in a minority of cases. {ECO:0000269|PubMed:14974090}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Atrioventricular septal defect 3 (AVSD3) [MIM:600309]: A congenital heart malformation characterized by a common atrioventricular junction coexisting with deficient atrioventricular septation. The complete form involves underdevelopment of the lower part of the atrial septum and the upper part of the ventricular septum; the valve itself is also shared. A less severe form, known as ostium primum atrial septal defect, is characterized by separate atrioventricular valvar orifices despite a common junction. {ECO:0000269|PubMed:11470490}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Craniometaphyseal dysplasia, autosomal recessive (CMDR) [MIM:218400]: An osteochondrodysplasia characterized by hyperostosis and sclerosis of the craniofacial bones associated with abnormal modeling of the metaphyses. Sclerosis of the skull may lead to asymmetry of the mandible, as well as to cranial nerve compression, that may finally result in hearing loss and facial palsy. {ECO:0000269|PubMed:23951358}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Erythrokeratodermia variabilis et progressiva 3 (EKVP3) [MIM:617525]: A form of erythrokeratodermia variabilis et progressiva, a genodermatosis characterized by the coexistence of two independent skin lesions: transient erythema and hyperkeratosis that is usually localized but occasionally occurs in its generalized form. Clinical presentation varies significantly within a family and from one family to another. Palmoplantar keratoderma is present in around 50% of cases. {ECO:0000269|PubMed:25398053}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Palmoplantar keratoderma and congenital alopecia 1 (PPKCA1) [MIM:104100]: A rare autosomal dominant disorder characterized by severe hyperkeratosis of the palms and soles, and congenital hypotrichosis or alopecia. Dystrophic nail changes occur in some patients. {ECO:0000269|PubMed:25168385}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Pathway
Arrhythmogenic right ventricular cardiomyopathy (ARVC) - Homo sapiens (human);Gap junction - Homo sapiens (human);Antiarrhythmic Pathway, Pharmacodynamics;TarBasePathway;miR-targeted genes in epithelium - TarBase;miR-targeted genes in muscle cell - TarBase;Arrhythmogenic Right Ventricular Cardiomyopathy;Corticotropin-releasing hormone signaling pathway;Spinal Cord Injury;Myometrial Relaxation and Contraction Pathways;Wnt Signaling Pathway;VEGFA-VEGFR2 Signaling Pathway;EGF-EGFR Signaling Pathway;Calcium Regulation in the Cardiac Cell;Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways;Vesicle-mediated transport;Membrane Trafficking;Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane;c-src mediated regulation of Cx43 function and closure of gap junctions;inactivation of gsk3 by akt causes accumulation of b-catenin in alveolar macrophages;EGFR1;Transport of connexins along the secretory pathway;Oligomerization of connexins into connexons;Transport of connexons to the plasma membrane;Gap junction assembly;Formation of annular gap junctions;Gap junction degradation;Gap junction trafficking;Regulation of gap junction activity;Gap junction trafficking and regulation;N-cadherin signaling events;AP-1 transcription factor network;Validated transcriptional targets of AP1 family members Fra1 and Fra2 (Consensus)

Recessive Scores

pRec
0.365

Intolerance Scores

loftool
0.108
rvis_EVS
-0.27
rvis_percentile_EVS
34.32

Haploinsufficiency Scores

pHI
0.952
hipred
Y
hipred_score
0.833
ghis
0.579

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.583

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Gja1
Phenotype
immune system phenotype; skeleton phenotype; hearing/vestibular/ear phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); limbs/digits/tail phenotype; vision/eye phenotype; reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); normal phenotype; hematopoietic system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); cellular phenotype; homeostasis/metabolism phenotype; muscle phenotype; craniofacial phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); growth/size/body region phenotype; endocrine/exocrine gland phenotype;

Zebrafish Information Network

Gene name
cx43
Affected structure
nucleate erythrocyte
Phenotype tag
abnormal
Phenotype quality
decreased amount

Gene ontology

Biological process
muscle contraction;signal transduction;cell-cell signaling;heart development;cell communication by electrical coupling;gap junction assembly;negative regulation of cell growth;ion transmembrane transport;positive regulation of I-kappaB kinase/NF-kappaB signaling;atrial cardiac muscle cell action potential;cell communication by electrical coupling involved in cardiac conduction;positive regulation of cold-induced thermogenesis
Cellular component
Golgi membrane;nucleoplasm;mitochondrion;endoplasmic reticulum membrane;Golgi apparatus;plasma membrane;integral component of plasma membrane;gap junction;connexin complex;focal adhesion;intercalated disc;apical plasma membrane;cell junction;Golgi-associated vesicle membrane;intracellular membrane-bounded organelle;membrane raft
Molecular function
gap junction channel activity;protein binding;ion transmembrane transporter activity;gap junction hemi-channel activity;gap junction channel activity involved in cardiac conduction electrical coupling;gap junction channel activity involved in cell communication by electrical coupling